Adial Pharmaceuticals Inc (ADIL)
1.76
+0.06
(+3.53%)
USD |
NASDAQ |
May 01, 16:00
1.79
+0.03
(+1.70%)
After-Hours: 20:00
Adial Pharmaceuticals Enterprise Value: 4.066M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 4.066M |
| April 29, 2024 | 4.026M |
| April 26, 2024 | 3.701M |
| April 25, 2024 | 4.188M |
| April 24, 2024 | 4.107M |
| April 23, 2024 | 4.066M |
| April 22, 2024 | 4.877M |
| April 19, 2024 | 4.999M |
| April 18, 2024 | 5.972M |
| April 17, 2024 | 6.580M |
| April 16, 2024 | 6.256M |
| April 15, 2024 | 7.756M |
| April 12, 2024 | 6.621M |
| April 11, 2024 | 9.256M |
| April 10, 2024 | 6.621M |
| April 09, 2024 | 1.755M |
| April 08, 2024 | 1.755M |
| April 05, 2024 | 1.877M |
| April 04, 2024 | 2.120M |
| April 03, 2024 | 2.201M |
| April 02, 2024 | 2.160M |
| April 01, 2024 | 2.160M |
| March 28, 2024 | -0.6148M |
| March 27, 2024 | -0.4983M |
| March 26, 2024 | -0.5565M |
| Date | Value |
|---|---|
| March 25, 2024 | -0.5815M |
| March 22, 2024 | 0.0007M |
| March 21, 2024 | 0.0173M |
| March 20, 2024 | 0.0839M |
| March 19, 2024 | -0.0825M |
| March 18, 2024 | -0.1157M |
| March 15, 2024 | -0.1989M |
| March 14, 2024 | 0.0672M |
| March 13, 2024 | 0.0839M |
| March 12, 2024 | 0.3334M |
| March 11, 2024 | 0.4997M |
| March 08, 2024 | 0.5995M |
| March 07, 2024 | 0.6993M |
| March 06, 2024 | 0.716M |
| March 05, 2024 | 1.814M |
| March 04, 2024 | 1.747M |
| March 01, 2024 | 2.596M |
| February 29, 2024 | 0.5663M |
| February 28, 2024 | -0.1324M |
| February 27, 2024 | -1.374M |
| February 26, 2024 | -1.463M |
| February 23, 2024 | -1.455M |
| February 22, 2024 | -1.430M |
| February 21, 2024 | -1.264M |
| February 20, 2024 | -1.114M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.463M
Minimum
Feb 26 2024
90.28M
Maximum
Sep 23 2021
18.19M
Average
9.620M
Median
Enterprise Value Benchmarks
| BioVie Inc | 9.872M |
| BioSig Technologies Inc | 18.43M |
| Precision BioSciences Inc | -22.27M |
| Humacyte Inc | 386.36M |
| Monogram Orthopaedics Inc | 52.21M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.920M |
| Total Expenses (Quarterly) | 1.784M |
| EPS Diluted (Quarterly) | -1.154 |
| Earnings Yield | -234.3% |